Mats Kalin

4.3k citations
71 papers · 3.2k indexed · h-index 31

Impact in

    • Bacterial Infections and Vaccines
    • Pneumonia and Respiratory Infections
    • Respiratory viral infections research
    • Pneumocystis jirovecii pneumonia detection and treatment

Papers in

    • Pneumonia and Respiratory Infections 31
    • Respiratory viral infections research 16
    • Pneumocystis jirovecii pneumonia detection and treatment 10
    • Bacterial Identification and Susceptibility Testing 9

Mats Kalin

71 papers receiving 3.1k citations

Peers

Mats Kalin
Comparison fields: 5 of 115
  • Microbiology 421
  • Epidemiology 2.2k
  • Molecular Medicine 299
  • Critical Care and Intensive Care Medicine 302
  • Applied Microbiology and Biotechnology 94
Replace R. Verdaguer with:
R. Verdaguer Spain
R. Finch United Kingdom
Heike von Baum Germany
Núria Sabé Spain
P.J. van den Broek Netherlands
Krow Ampofo United States
Paula Peyrani United States
Theodore C. Eickhoff United States
Baldwin Toye Canada
José Bordón United States
Mats Kalin relative to R. Verdaguer Spain R. Verdaguer's profile →
Citations per field
00.5×1.6×
R. Verdaguer · 1×
Citations per year

Countries citing papers authored by Mats Kalin

Since Specialization
Citations

This map shows the geographic impact of Mats Kalin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Kalin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Kalin more than expected).

Fields of papers citing papers by Mats Kalin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mats Kalin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Kalin. The network helps show where Mats Kalin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mats Kalin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mats Kalin Line = papers co-authored together Mats Kalin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201527
2 201426
3 201436
4 201237
5 201216
6 201151
7 201048
8 2007227
9 200741
10 200555
11 2000137
12 1998283
13 19973
14 199610
15 199582
16 199346
17 199112
18 198515
19 198388
20 198382

About Mats Kalin

Mats Kalin is a scholar working on Epidemiology, Clinical Biochemistry, Microbiology, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 71 papers that have together received 3.2k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (31 papers), Respiratory viral infections research (16 papers), Neutropenia and Cancer Infections (14 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers), Bacterial Identification and Susceptibility Testing (9 papers), Bacterial Infections and Vaccines (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers) and Emergency and Acute Care Studies (6 papers). The work is most often cited by research in Microbiology (421 citations), Epidemiology (2.2k citations), Molecular Medicine (299 citations), Critical Care and Intensive Care Medicine (302 citations) and Applied Microbiology and Biotechnology (94 citations). Mats Kalin has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Jonas Hedlund, Åke Örtqvist, Christian G. Giske, Niclas Johansson, Alf A. Lindberg, Magnus Björkholm, Honar Cherif, Annika Tiveljung‐Lindell, Inger Julander and Maija Leinonen. Their work appears in journals such as European Journal Of Haematology, The Lancet, The Journal of Infectious Diseases, Clinical Infectious Diseases and Microbial Drug Resistance.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026